Vifor Pharma announces changes to its Executive Committee

2021年10月13日 19:25:21 来自: (0)参与

Executive committee members Lee Heeson and Gregory Oakes to leave the company for personal reasons
Succession planning ongoing

ST. GALLEN, Switzerland--(BUSINESS WIRE)--Regulatory News:

AD HOC ANNOUNCEMENT PURSUANT TO ART. 53 LR

Vifor Pharma Group today announced changes to its Executive Committee as current members Lee Heeson, President International, and Gregory Oakes, President North America, have decided to leave the company for personal reasons. Succession planning is currently underway and will be announced once the process has been concluded.

In parallel to these management changes, Vifor Pharma is pleased that Molly Painter is joining the company as President U.S., effective as of 18 October 2021. Molly has a proven track record of building and leading organizations across multiple therapeutic areas, and extensive experience in launching and commercializing products in the U.S..

Abbas Hussain, Chief Executive Officer of Vifor Pharma Group, commented: “I am delighted to welcome Molly Painter to Vifor Pharma. She brings a wealth of experience with over 20 years in the healthcare industry. I want to thank Lee and Greg for their contributions to Vifor Pharma and to the Executive Committee, especially for their commitment and leadership of the organization during the COVID-19 pandemic. I wish them the very best for their future endeavours, both professionally and personally.”

About Vifor Pharma Group
Vifor Pharma Group is a global pharmaceuticals company. It aims to become the global leader in iron deficiency, nephrology and cardio-renal therapies. The company is a partner of choice for pharmaceuticals and innovative patient-focused solutions. Vifor Pharma Group strives to help patients around the world with severe and chronic diseases lead better, healthier lives. The company develops, manufactures and markets pharmaceutical products for precision patient care. Vifor Pharma Group holds a leading position in all its core business activities and consists of the following companies: Vifor Pharma and Vifor Fresenius Medical Care Renal Pharma (a joint company with Fresenius Medical Care). Vifor Pharma Group is headquartered in Switzerland, and listed on the Swiss Stock Exchange (SIX Swiss Exchange, VIFN, ISIN: CH0364749348).

For more information, please visit viforpharma.com.

相关新闻
网易网友:惜一丝清冷
评论:小时候哭着哭着就笑了,长大后笑着笑着就哭了。

其它网友:腐朽Eros1on
评论:哥,不寂寞。因为有寂寞陪着哥。

凤凰网友:真的我爱你
评论:母亲 。一天的公主。十个月的皇后。一辈子的操劳。

本网网友:猥琐纠结之美
评论:“高富帅官二代”这六个字,我想我只做到了第五个字。

猫扑网友:迷局  Memory 
评论:吃货都是善良的,因为每天只想着吃,没时间去算计别人

搜狐网友:以死换温柔◇
评论:恋爱需要实习,分手需要练习。

百度网友:没你爸风骚 -
评论:活在自己的心里,不要活在别人的眼里。

天涯网友:不帶這么玩的
评论:好的文字是这样的:你写得不动声色,我看得肝肠寸断

天猫网友:没感觉  End.ゝ
评论:钱多钱少,够吃就好。人丑人美,顺眼就好。人老人少,健康就好。家穷家富,和气就好。

淘宝网友:苏素/mmmmm
评论:我以前对你掏心掏肺 你却对我狼心狗肺 搞得我现在没心没肺

新闻转自网络媒体,如有侵权,请与我们联系:1160322105@qq.com责编:admin